Literature DB >> 16873253

Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.

Qiliang Cai1, Ke Lan, Subhash C Verma, Huaxin Si, Doug Lin, Erle S Robertson.   

Abstract

Hypoxia can induce lytic replication of Kaposi's sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma (PEL) cells. However, the molecular mechanism of lytic reactivation of KSHV by hypoxia remains unclear. Here we show that the latency-associated nuclear antigen (LANA), which plays a crucial role in modulating viral and cellular gene expression, directly associated with a low oxygen responder, hypoxia-inducible factor-1 alpha (HIF-1 alpha). LANA enhanced not only the transcriptional activities of HIF-1 alpha but also its mRNA level. Coimmunoprecipitation and immunofluorescence studies documented a physical interaction between LANA and HIF-1 alpha in transiently transfected 293T cells as well as in PEL cell lines during hypoxia. Through sequence analysis, several putative hypoxia response elements (HRE-1 to -6) were identified in the essential lytic gene Rta promoter. Reporter assays showed that HRE-2 (-1130 to -1123) and HRE-5 and HRE-6 (+234 to +241 and +812 to +820, respectively, within the intron sequence) were necessary and sufficient for the LANA-mediated HIF-1 alpha response. Electrophoretic mobility shift assays showed HIF-1 alpha-dependent binding of a LANA protein complex specifically to the HRE-2, -5, and -6 motifs within the promoter regulatory sequences. This study demonstrates that hypoxia-induced KSHV lytic replication is mediated at least in part through cooperation of HIF-1 alpha with LANA bound to the HRE motifs of the Rta promoter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873253      PMCID: PMC1563785          DOI: 10.1128/JVI.00689-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus.

Authors:  F X Zhu; T Cusano; Y Yuan
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Influence of the hypoxic subvolume on the survival of patients with head and neck cancer.

Authors:  P Stadler; A Becker; H J Feldmann; G Hänsgen; J Dunst; F Würschmidt; M Molls
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

3.  Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.

Authors:  Ke Lan; Daniel A Kuppers; Erle S Robertson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Role of CBP in regulating HIF-1-mediated activation of transcription.

Authors:  Jorge L Ruas; Lorenz Poellinger; Teresa Pereira
Journal:  J Cell Sci       Date:  2004-12-22       Impact factor: 5.285

5.  HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR.

Authors:  E Minet; I Ernest; G Michel; I Roland; J Remacle; M Raes; C Michiels
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

6.  Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.

Authors:  Koami Dagnon; Emilie Pacary; Frédéric Commo; Martine Antoine; Myriam Bernaudin; Jean-Francois Bernaudin; Patrice Callard
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

7.  STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.

Authors:  Joo Eun Jung; Hyun Gyu Lee; Ik Hyun Cho; Doo Hyun Chung; Sun-Hee Yoon; Young Mok Yang; Jung Weon Lee; Seongwon Choi; Jong-Wan Park; Sang-Kyu Ye; Myung-Hee Chung
Journal:  FASEB J       Date:  2005-05-26       Impact factor: 5.191

8.  Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.

Authors:  D M Lukac; J R Kirshner; D Ganem
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

9.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.

Authors:  D H Kedes; M Lagunoff; R Renne; D Ganem
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Tumor hypoxia in pelvic recurrences of cervical cancer.

Authors:  M Höckel; K Schlenger; S Höckel; B Aral; U Schäffer; P Vaupel
Journal:  Int J Cancer       Date:  1998-08-21       Impact factor: 7.396

View more
  77 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus.

Authors:  Jana Tomaskova; Ingrid Oveckova; Martina Labudova; Lubomira Lukacikova; Katarina Laposova; Juraj Kopacek; Silvia Pastorekova; Jaromir Pastorek
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

5.  Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.

Authors:  Thilo Hagen
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

Review 6.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 7.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

8.  The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway.

Authors:  Muzammel Haque; Konstantin G Kousoulas
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.

Authors:  Duosha Hu; Victoria Wang; Min Yang; Shahed Abdullah; David A Davis; Thomas S Uldrick; Mark N Polizzotto; Ravindra P Veeranna; Stefania Pittaluga; Giovanna Tosato; Robert Yarchoan
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 10.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.